
    
      This study will test the hypothesis that the vasodilation associated with capsaicin-induced
      dermal blood flow (DBF) provides a good model for the vasodilation associated with hot
      flashes; therefore erenumab doses that cause DBF inhibition will be safe and well tolerated,
      and will be effective in the reduction of the frequency and/or severity of HFs.
    
  